Positrigo

About Positrigo

Positrigo is a Other / Uncategorized company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Endpoints News · 2026-12-13
  Positrigo signs supply agreement to support late-stage trials
  The work builds on more than a decade of radiochemistry collaboration.
• Reuters Health · 2026-03-06
  Positrigo appoints new Chief Medical Officer ahead of pivotal trial
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• BioPharma Reporter · 2026-02-11
  Positrigo announces Phase II readout for lead theranostic candidate
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• FierceBiotech · 2026-09-04
  Positrigo expands cyclotron capacity to meet Lu-177 demand
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.